Tech Company Financing Transactions

4D Molecular Therapeutics Funding Round

4D Molecular Therapeutics closed a $3 million financing round on 9/20/2017. Investors included Cystic Fibrosis Foundation.

Transaction Overview

Announced On
9/20/2017
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Proceeds Purpose
This additional investment will accelerate IND enabling studies and initiation of clinical testing in CF patients with high unmet medical needs.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5858 Horton St. 455
Emeryville, CA 94608
USA
Email Address
Overview
4D Molecular Therapeutics (Nasdaq: FDMT) designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.
Profile
4D Molecular Therapeutics LinkedIn Company Profile
Social Media
4D Molecular Therapeutics Company Twitter Account
Company News
4D Molecular Therapeutics News
Facebook
4D Molecular Therapeutics on Facebook
YouTube
4D Molecular Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Kirn
  David Kirn LinkedIn Profile  David Kirn Twitter Account  David Kirn News  David Kirn on Facebook
Chief Financial Officer
August Moretti
  August Moretti LinkedIn Profile  August Moretti Twitter Account  August Moretti News  August Moretti on Facebook
Chief Operating Officer
Theresa Janke
  Theresa Janke LinkedIn Profile  Theresa Janke Twitter Account  Theresa Janke News  Theresa Janke on Facebook
Chief Scientific Officer
Peter Francis
  Peter Francis LinkedIn Profile  Peter Francis Twitter Account  Peter Francis News  Peter Francis on Facebook
Chief Technical Officer
Fred Kamal
  Fred Kamal LinkedIn Profile  Fred Kamal Twitter Account  Fred Kamal News  Fred Kamal on Facebook
VP - Human Resources
Jessica Wilan
  Jessica Wilan LinkedIn Profile  Jessica Wilan Twitter Account  Jessica Wilan News  Jessica Wilan on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/20/2017: Aqua Security venture capital transaction
Next: 9/20/2017: MealPal venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary